COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences (NASDAQ:COGT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress [Yahoo! Finance]
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at HC Wainwright from $21.00 to $50.00. They now have a "buy" rating on the stock.
Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed? [Yahoo! Finance]
Form 8-K Cogent Biosciences, Inc. For: Nov 18
Form SCHEDULE 13D/A Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Commodore Capital LP
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: TCG Crossover GP I, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.